Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02637427 · ClinicalTrials.gov registry record · Phase 3
Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
A Phase 3 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 3
- Development phase
- 57
- Enrollment target
NCT02637427 is a Phase 3 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 57 participants.
The verdict
NCT02637427, a Phase 3 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate prophylactic fresh frozen plasma transfusion in patients with moderately elevated international normalized ratios (INR) prior to undergoing an invasive procedure.
Interventions
- BIOLOGICAL Fresh frozen plasma transfusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-02-26 |
| Est. Completion | 2020-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02637427
The ClinicalTrials.gov registry entry for NCT02637427 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fresh frozen plasma transfusion is the first listed.
NCT02637427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02637427 about?
NCT02637427 is a clinical study titled "Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures". The purpose of this study is to evaluate prophylactic fresh frozen plasma transfusion in patients with moderately elevated international normalized ratios (INR) prior to undergoing an invasive procedure.
What is the current status of trial NCT02637427?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 57 participants. The study started on 2016-02-26. Estimated completion is 2020-11.
What interventions are being tested in trial NCT02637427?
The interventions under investigation include: Fresh frozen plasma transfusion (BIOLOGICAL).
Who is sponsoring clinical trial NCT02637427?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.